health-it is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention Corexa Health, the most common co-covered peer. The 5 average consequence score is below the beat benchmark of 5.2 in the same window.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Tollovid
health-it is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention Corexa Health, the most common co-covered peer. The 5 average consequence score is below the beat benchmark of 5.2 in the same window. Each story carries 2 original sources on average, compared with 2.2 for the broader beat in this window. Tollovid appears in 1 tracked Healthcare story from August 12, 2026.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 40 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Tollovid. Shared-story counts are live from our verified record — not editorial picks.
Health IT firm DataMeds AI uses its EinsteinRx AI and PharmacyChain blockchain platforms to power a direct-to-consumer pharmacy launch of Long COVID supplements, with a market projected to reach $32.8B. A pending acquisition of the product maker adds vertical integration.